ArteraAI Prostate
Jul 2025
248d
Artera, Inc. has submitted 1 FDA 510(k) premarket notifications since 2025, of which 0 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Pathology Software Algorithm Device Analyzing Digital Images For Cancer Prognosis . Use the specialty filter in the sidebar to narrow results.